Zubin Grover1, Peter Lewindon2. 1. Princess Margaret Hospital for Children, Perth, Australia. zubingrover@gmail.com. 2. University of Queensland School of Medicine, Brisbane, QLD, Australia.
Abstract
BACKGROUND: Impact of first-line induction therapy on medium-term outcomes in the setting of early thiopurine (TP) use in children with Crohn's disease has not been evaluated, in particular whether choice of exclusive enteral nutrition (EEN) over corticosteroids (CS) for induction impacts clinical outcomes at 12 and 24 months. AIMS AND METHODS: In this retrospective study, 89 children from our database with new diagnosis CD and follow-up of at least 2 years following induction with exclusive course of CS or EEN and early, dose-optimized TP (within 6 months from diagnosis) were evaluated. We compared steroid dependency (relapse <3 months of tapering first course CS or inability to wean <10 mg prednisolone), need for IFX, linear growth, and surgical resections over the first 2 years. RESULTS: Choice of EEN over CS induction was associated with reduced linear growth failure (7 vs. 26%, p = 0.02), CS dependency (7 vs. 43%, p = 0.002), and improved primary sustained response to IFX (86 vs. 68%, p = 0.02). Combined CS/IFX-free remission and surgical resection rates were similar. CONCLUSION: In the setting of early TP commencement, EEN induction is superior to CS induction for reducing growth failure, CS dependency, and loss of response to IFX over the first 2 years.
BACKGROUND: Impact of first-line induction therapy on medium-term outcomes in the setting of early thiopurine (TP) use in children with Crohn's disease has not been evaluated, in particular whether choice of exclusive enteral nutrition (EEN) over corticosteroids (CS) for induction impacts clinical outcomes at 12 and 24 months. AIMS AND METHODS: In this retrospective study, 89 children from our database with new diagnosis CD and follow-up of at least 2 years following induction with exclusive course of CS or EEN and early, dose-optimized TP (within 6 months from diagnosis) were evaluated. We compared steroid dependency (relapse <3 months of tapering first course CS or inability to wean <10 mg prednisolone), need for IFX, linear growth, and surgical resections over the first 2 years. RESULTS: Choice of EEN over CS induction was associated with reduced linear growth failure (7 vs. 26%, p = 0.02), CS dependency (7 vs. 43%, p = 0.002), and improved primary sustained response to IFX (86 vs. 68%, p = 0.02). Combined CS/IFX-free remission and surgical resection rates were similar. CONCLUSION: In the setting of early TP commencement, EEN induction is superior to CS induction for reducing growth failure, CS dependency, and loss of response to IFX over the first 2 years.
Authors: R Berni Canani; G Terrin; O Borrelli; M T Romano; F Manguso; A Coruzzo; F D'Armiento; E F Romeo; S Cucchiara Journal: Dig Liver Dis Date: 2005-11-18 Impact factor: 4.088
Authors: Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths Journal: J Pediatr Gastroenterol Nutr Date: 2005-10 Impact factor: 2.839
Authors: S Sazuka; T Katsuno; T Nakagawa; M Saito; K Saito; T Matsumura; M Arai; T Sato; O Yokosuka Journal: Eur J Clin Nutr Date: 2012-09-26 Impact factor: 4.016
Authors: Jessica J Lee; Johanna C Escher; Melissa J Shuman; Peter W Forbes; Luçan C Delemarre; Brian W Harr; Marjan Kruijer; Marlous Moret; Sophie Allende-Richter; Richard J Grand Journal: Inflamm Bowel Dis Date: 2010-10 Impact factor: 5.325
Authors: Brendan M Boyle; Michael D Kappelman; Richard B Colletti; Robert N Baldassano; David E Milov; Wallace V Crandall Journal: World J Gastroenterol Date: 2014-07-21 Impact factor: 5.742
Authors: Alain M Schoepfer; Christoph Beglinger; Alex Straumann; Michael Trummler; Stephan R Vavricka; Lukas E Bruegger; Frank Seibold Journal: Am J Gastroenterol Date: 2009-09-15 Impact factor: 10.864
Authors: Charlotte M Verburgt; Mohammed Ghiboub; Marc A Benninga; Wouter J de Jonge; Johan E Van Limbergen Journal: Nutrients Date: 2021-01-13 Impact factor: 5.717